Heparin inhibits ligand binding to the leukocyte integrin Mac-1 (CD11b/CD18)

被引:108
|
作者
Peter, K
Schwarz, M
Conradt, C
Nordt, T
Moser, M
Kübler, W
Bode, C
机构
[1] Univ Freiburg, Dept Internal Med 3, D-79106 Freiburg, Germany
[2] Univ Freiburg, Dept Biometry, D-79106 Freiburg, Germany
关键词
heparin; cell adhesion molecules; leukocytes; fibrinogen;
D O I
10.1161/01.CIR.100.14.1533
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-The clinical benefits of heparin reach beyond its anticoagulative properties. Recently, it has been described that leukocytes adhere on immobilized heparin mediated by the integrin Mac-1 (CD11b/CD18, alpha(M)beta(2), or CR3). Because inhibition of this versatile adhesion molecule could explain various aspects of the beneficial clinical effects of heparin, we evaluated whether soluble heparin modulates Mac-1 function in vitro and in vivo. Methods and Results-Binding of unfractionated heparin to Mac-1 on PMA-stimulated monocytes and granulocytes was directly demonstrated in flow cytometry, whereas no binding of heparin was detected on unstimulated leukocytes. Unfractionated heparin inhibited binding of the soluble ligands fibrinogen, factor X, and iC3b to Mac-1. Adhesion of the monocytic cell line THP-1 and of peripheral monocytes and granulocytes to immobilized ICAM-1 was impaired by unfractionated heparin, to the same extent as with inhibition of Mac-1 by monoclonal antibodies such as c7E3. Low-molecular-weight heparin also inhibits binding of fibrinogen to Mac-1. Additionally, flow cytometry of whole blood preparations of patients treated with unfractionated heparin revealed an inhibitory effect of heparin on the binding of fibrinogen to Mac-1 that correlates (n = 48, r = 0.63, P < 0.001) to the extent of prolongation of the activated partial thromboplastin time. Conclusions-We describe a pharmacologically relevant property of heparin that may contribute to its benefits in clinical use. The binding of heparin to Mac-1 and the resulting inhibition in binding of Mac-1 ligands may directly modulate coagulation, inflammation, and cell proliferation.
引用
收藏
页码:1533 / 1539
页数:7
相关论文
共 50 条
  • [41] Regulation of MAC-1 (CD11b/CD18) expression on circulating granulocytes in endurance runners
    Jordan, J
    Beneke, R
    Hütler, M
    Veith, A
    Luft, FC
    Haller, H
    MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 1999, 31 (03): : 362 - 367
  • [42] Mac-1 (CD11b/CD18) mediates tyrosine signaling in human neutrophils.
    Walzog, B
    Zakrzewicz, A
    Ley, K
    Gaehtgens, P
    FASEB JOURNAL, 1996, 10 (03): : 3999 - 3999
  • [43] Regulation of CD11b/CD18 (Mac-1) adhesion to fibrinogen by urokinase receptor (uPAR)
    H. Zhang
    R. W. Colman
    N. Sheng
    Inflammation Research, 2003, 52 : 86 - 93
  • [44] ALTERNATIVE FIBRINOLYSIS MEDIATED BY MAC-1 (CD11B/CD18) AND CATHEPSIN-D
    SIMON, DI
    EZRATTY, A
    LOSCALZO, J
    CIRCULATION, 1993, 88 (04) : 616 - 616
  • [45] QUANTITATION OF INTRACELLULAR MAC-1 (CD11B CD18) POOLS IN HUMAN-NEUTROPHILS
    JONES, DH
    ANDERSON, DC
    BURR, BL
    RUDLOFF, HE
    SMITH, CW
    KRATER, SS
    SCHMALSTIEG, FC
    JOURNAL OF LEUKOCYTE BIOLOGY, 1988, 44 (06) : 535 - 544
  • [46] EPIDERMOTROPIC NEUTROPHILIC GRANULOCYTES EXPRESS MAC-1 (CD11B/CD18) RATHER THAN LFA-1 (CD11A/CD18)
    VONDENDRIESCH, P
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 1993, 285 (07) : 444 - 446
  • [47] THE CD11B/CD18 (MAC-1) LEUKOCYTE INTEGRIN MEDIATES CELL - CELL ADHERENCE OF TRANSFECTED K562 LEUKEMIA-CELLS
    GRUNVALD, EL
    HICKSTEIN, DD
    CLINICAL RESEARCH, 1993, 41 (01): : A20 - A20
  • [48] The GP IIb/IIIa inhibitor abciximab (c7E3) inhibits the binding of various ligands to the leukocyte integrin Mac-1 (CD11b/CD18, αMβ2)
    Schwarz, M
    Nordt, T
    Bode, C
    Peter, K
    THROMBOSIS RESEARCH, 2002, 107 (3-4) : 121 - 128
  • [49] THE LEUKOCYTE INTEGRIN, CD11B/CD18, IS EXPRESSED BY RABBIT ARTICULAR CHONDROCYTES
    TIKU, ML
    TIKU, K
    LIESCH, JB
    ARTHRITIS AND RHEUMATISM, 1992, 35 (09): : S137 - S137
  • [50] SUBCELLULAR-DISTRIBUTION AND MOBILIZATION OF MAC-1 (CD11B/CD18) IN NEONATAL NEUTROPHILS
    JONES, DH
    SCHMALSTIEG, FC
    DEMPSEY, K
    KRATER, SS
    NANNEN, DD
    SMITH, CW
    ANDERSON, DC
    BLOOD, 1990, 75 (02) : 488 - 498